Printer Friendly Version

Send to a Friend

The University of Maryland, Baltimore dedicated Building Two at its BioPark development in April of 2008. The six-story, 238,000-sf research facility will house tenants including the Institute for Genome Services, Gliknik, Paragon Bioservices, Westat, and the 38,000-sf Baltimore City Community College’s Bioscience Institute. The first two BioPark buildings were developed by Wexford Science & Technology. UMB broke ground on Building Three in spring of 2008. BioPark’s $500 million, 1.2 million-sf campus will be comprised of ten buildings upon completion. Current tenants include MiddleBrook Pharmaceuticals, SNBL Clinical Pharmacology Center, Alba Therapeutics, FASgen, Irazu BioDiscovery, and Acidophil.